WuXi Biologics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	18,110	8,966	14,476	30,347	44,084	44,275
Market Cap Growth	95.87%	-38.06%	-52.30%	-31.16%	-0.43%	203.05%
Enterprise Value	17,715	8,835	14,219	29,722	42,867	44,097
Last Close Price	4.37	2.17	3.36	7.20	-	-
PE Ratio	36.31	20.19	33.37	50.61	93.99	209.36
PS Ratio	7.60	3.63	6.66	14.65	30.95	63.00
PB Ratio	3.11	1.49	2.58	6.18	9.74	16.92
P/TBV Ratio	3.54	1.70	2.96	6.79	10.56	17.69
P/FCF Ratio	86.61	52.62	182.37	-	-	-
P/OCF Ratio	26.63	12.99	24.31	40.37	92.82	187.95
EV/Sales Ratio	7.42	3.58	6.54	14.35	30.10	62.75
EV/EBITDA Ratio	21.39	11.42	22.61	43.22	85.50	198.82
EV/EBIT Ratio	27.11	14.56	28.34	50.36	97.69	234.41
EV/FCF Ratio	84.72	51.85	179.13	-	-	-
Debt / Equity Ratio	0.10	0.11	0.10	0.12	0.13	0.16
Debt / EBITDA Ratio	0.73	0.82	0.89	0.86	1.18	1.85
Debt / FCF Ratio	2.90	3.84	7.33	-	-	-
Net Debt / Equity Ratio	-0.15	-0.13	-0.15	-0.12	-0.21	-0.25
Net Debt / EBITDA Ratio	-1.09	-0.99	-1.36	-0.85	-1.89	-2.91
Net Debt / FCF Ratio	-4.22	-4.48	-10.74	13.14	2.22	1.24
Asset Turnover	0.34	0.33	0.32	0.33	0.28	0.24
Inventory Turnover	6.36	6.71	5.04	4.31	3.94	4.15
Quick Ratio	2.40	1.98	2.35	1.56	1.85	2.49
Current Ratio	2.88	2.73	2.78	1.98	2.37	3.16
Return on Equity (ROE)	10.51%	8.82%	8.90%	13.20%	13.09%	10.02%
Return on Assets (ROA)	5.89%	5.05%	4.63%	5.81%	5.43%	4.03%
Return on Invested Capital (ROIC)	10.55%	9.71%	9.72%	12.78%	13.38%	10.74%
Return on Capital Employed (ROCE)	10.60%	9.50%	8.00%	10.80%	8.90%	6.10%
Earnings Yield	2.75%	4.95%	3.00%	1.98%	1.06%	0.48%
FCF Yield	1.15%	1.90%	0.55%	-0.15%	-0.97%	-1.17%
Buyback Yield / Dilution	2.55%	2.80%	0.62%	1.04%	-5.05%	-5.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.